The relationship between antiangiogenic therapy and metastasis remains to be determined and is an important topic for future research. Further study may provide additional drug targets, resulting in adjuvant therapies that can enhance the clinical benefits of antiangiogenic treatment. Acknowledgements We thank Jing Zhou for technical assistance. References 1. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285:1182–1186.PubMedCrossRef 2. Samaranayake

H, Määttä AM, Pikkarainen J, Ylä-Herttuala S: Future prospects and challenges of antiangiogenic cancer gene therapy. Hum Gene Ther 2010,21(4):381–96.PubMedCrossRef 3. Kerbel RS: Tumor angiogenesis. N Engl J Med 2008, 358:2039–2049.PubMedCrossRef 4. Jain RK: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58–62.PubMedCrossRef 5. Qu B, Guo L, Ma Selleckchem Caspase inhibitor J, Lv Y: Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system. Med Hypotheses 2010,74(2):360–361.PubMedCrossRef 6. Casanovas O, Hicklin DJ, Bergers G, Hanahan D: Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage HDAC cancer pancreatic islet tumors. Cancer Cell 2005, 8:299–309.PubMedCrossRef 7. Rubenstein JL, beta-catenin cancer Kim J, Ozawa T, Zhang M, Westphal

M, Deen DF, Shuman MA: Anti-

VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2000, 2:306–314.PubMedCrossRef 8. Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R, Stavrou D, Westphal M, Lamszus K: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 2001, 61:6624–6628.PubMed 9. Cong R, Sun Q, Yang L, Gu H, Zeng Y, Wang B: Effect of Genistein on vasculogenic Phosphoglycerate kinase mimicry formation by human uveal melanoma cells. J Exp Clin Cancer Res 2009, 28:124.PubMedCrossRef 10. Miyamoto T, Min W, Lillehoj HS: Lymphocyte proliferation response during Eimeria tenella infection assessed by a new, reliable, nonradioactive colorimetric assay. Avian Dis 2002, 46:10–16.PubMedCrossRef 11. Pölcher M, Eckhardt M, Coch C, Wolfgarten M, Kübler K, Hartmann G, Kuhn W, Rudlowski C: Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer. Cancer Chemother Pharmacol 2010. DOI 10. 1007/s00280–010–1276–2 12. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS: Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15:232–239.PubMedCrossRef 13.